Semin intervent Radiol 2021; 38(01): 139-143
DOI: 10.1055/s-0041-1724016
Morbidity & Mortality

Postcontrast Acute Kidney Injury After Transarterial Chemoembolization

Ali Kord
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Simon J. Park
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Amith Rao
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Atul Eppurath
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Andrew Lipnik
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
,
Charles E. Ray
1   Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois
› Author Affiliations

Intravascular (IV) administration of contrast media (CM) is commonly utilized to enhance the capabilities of imaging modalities commonplace in both diagnostic and therapeutic interventions. There are numerous iatrogenic reactions associated with CM administration that have been described in literature,[1] broadly categorized as allergic and nonallergic. Postcontrast acute kidney injury (PC-AKI) is a subset of nonallergic CM reactions and is especially important in patients with an underlying medical condition such as chronic kidney disease (CKD). This may be exacerbated by IV administration of CM during long interventional procedures such as angiography. In this article, a case of PC-AKI is presented followed by a discussion of the topic. In addition, guidelines for prevention and treatment of PC-AKI are presented.



Publication History

Article published online:
15 April 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 American Board of Radiology. Noninterpretive Skills. 2020: 23-29 . Accessed September 15, 2020 at: https://www.theabr.org/wp-content/uploads/2020/02/NIS-Study-Guide-2020.pdf
  • 2 Stacul F, van der Molen AJ, Reimer P. et al; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21 (12) 2527-2541
  • 3 ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media: ACR. 2020: 33-45 . Accessed September 15, 2020 at: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf
  • 4 The Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guideline for acute kidney injury. Kidney Int 2012; 2: 1-113
  • 5 van der Molen AJ, Reimer P, Dekkers IA. et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018; 28 (07) 2845-2855
  • 6 Davenport MS, Perazella MA, Yee J. et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 2020; 294 (03) 660-668
  • 7 Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38 (05) 292-299
  • 8 Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A. Acute kidney injury by radiographic contrast media: pathogenesis and prevention. BioMed Res Int 2014; 2014: 362725
  • 9 Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005; 20 (08) 1542-1550
  • 10 Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. BioMed Res Int 2014; 2014: 741018
  • 11 Kohan DE, Inscho EW, Wesson D, Pollock DM. Physiology of endothelin and the kidney. Compr Physiol 2011; 1 (02) 883-919
  • 12 Margulies KB, Hildebrand FL, Heublein DM, Burnett Jr JC. Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991; 2 (05) 1041-1045
  • 13 Ulas T, Buyukhatipoglu H, Dal MS. et al. Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 2013; 18 (03) 205-209
  • 14 Heyman SN, Rosenberger C, Rosen S, Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?. BioMed Res Int 2013; 2013: 123589
  • 15 Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 2008; 4 (05) 1061-1068
  • 16 Lee J. Nitric oxide in the kidney: its physiological role and pathophysiological implications. Electrolyte Blood Press 2008; 6 (01) 27-34
  • 17 Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol 2017; 6 (03) 86-99
  • 18 Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68 (01) 14-22
  • 19 Pattharanitima P, Tasanarong A. Pharmacological strategies to prevent contrast-induced acute kidney injury. BioMed Res Int 2014; 2014: 236930
  • 20 Solomon R. Contrast media: are there differences in nephrotoxicity among contrast media?. BioMed Res Int 2014; 2014: 934947
  • 21 Bucher AM, De Cecco CN, Schoepf UJ. et al. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?. BioMed Res Int 2014; 2014: 931413
  • 22 Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 2000; 75 (12) 1275-1283
  • 23 Mueller C, Buerkle G, Buettner HJ. et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162 (03) 329-336
  • 24 Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008; 3 (01) 273-280
  • 25 Merten GJ, Burgess WP, Gray LV. et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291 (19) 2328-2334
  • 26 Zoungas S, Ninomiya T, Huxley R. et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151 (09) 631-638
  • 27 Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One 2013; 8 (03) e60009
  • 28 Søreide E, Ljungqvist O. Modern preoperative fasting guidelines: a summary of the present recommendations and remaining questions. Best Pract Res Clin Anaesthesiol 2006; 20 (03) 483-491
  • 29 Subramaniam RM, Suarez-Cuervo C, Wilson RF. et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016; 164 (06) 406-416
  • 30 Pappy R, Stavrakis S, Hennebry TA, Abu-Fadel MS. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol 2011; 151 (03) 348-353
  • 31 Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012; 7 (04) e34450